Development of a Physiologically-Based Pharmacokinetic Model of Δ9-Tetrahydrocannabinol in Mice, Rats, and Pigs

被引：0
|
作者：
Janthima Methaneethorn
Kanyamas Naosang
Parichart Kaewworasut
Chomkanang Poomsaidorn
Manupat Lohitnavy
机构：
[1] Naresuan University,Pharmacokinetic Research Unit, Faculty of Pharmaceutical Sciences
[2] Naresuan University,Center of Excellence for Environmental Health and Toxicology
[3] Naresuan University,Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2020年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 494
页数：7
相关论文
共 50 条
  • [1] Development of a Physiologically-Based Pharmacokinetic Model of Δ9-Tetrahydrocannabinol in Mice, Rats, and Pigs
    Methaneethorn, Janthima
    Naosang, Kanyamas
    Kaewworasut, Parichart
    Poomsaidorn, Chomkanang
    Lohitnavy, Manupat
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (04) : 487 - 494
  • [2] A Δ9-Tetrahydrocannabinol Physiologically-Based Pharmacokinetic Model Development in Humans
    Methaneethorn, Janthima
    Poomsaidorn, Chomkanang
    Naosang, Kanyamas
    Kaewworasut, Parichart
    Lohitnavy, Manupat
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (04) : 495 - 511
  • [3] A Δ9-Tetrahydrocannabinol Physiologically-Based Pharmacokinetic Model Development in Humans
    Janthima Methaneethorn
    Chomkanang Poomsaidorn
    Kanyamas Naosang
    Parichart Kaewworasut
    Manupat Lohitnavy
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 495 - 511
  • [4] Pharmacokinetics and development of a physiologically-based pharmacokinetic model of docetaxel in mice
    Bradshaw-Pierce, Erica L.
    Merz, Andrea L.
    Zirrolli, Joseph A.
    Gustafson, Daniel L.
    CANCER RESEARCH, 2006, 66 (08)
  • [5] Physiologically-based pharmacokinetic modeling of genistein in rats, part I: Model development
    Schlosser, PM
    Borghoff, SJ
    Coldham, NG
    David, JA
    Ghosh, SK
    RISK ANALYSIS, 2006, 26 (02) : 483 - 500
  • [6] The development of a stochastic physiologically-based pharmacokinetic model for lead
    Beck, BD
    Mattuck, RL
    Bowers, TS
    Cohen, JT
    O'Flaherty, E
    SCIENCE OF THE TOTAL ENVIRONMENT, 2001, 274 (1-3) : 15 - 19
  • [7] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ACETONE
    KUMAGAI, S
    MATSUNAGA, I
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1995, 52 (05) : 344 - 352
  • [8] DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF CANAGLIFLOZIN IN HUMANS.
    Courtois, K.
    Rower, J. E.
    Bradshaw-Pierce, E. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S35 - S35
  • [9] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE ANTIBIOTIC ERTAPENEM
    Joyner, Michele L.
    Manning, Cammey C.
    Forbes, Whitney
    Maiden, Michelle
    Nikas, Ariel N.
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2016, 13 (01) : 119 - 133
  • [10] A physiologically-based pharmacokinetic (PBPK) model of hydroxychloroquine
    Collins, Keagan P.
    Jackson, Kristen M.
    Gustafson, Daniel L.
    CANCER RESEARCH, 2017, 77
12345